المؤلفون: Adrien Joseph, Bérangère S. Joly, Adrien Picod, Agnès Veyradier, Paul Coppo

المصدر: Journal of Clinical Medicine, Vol 12, Iss 9, p 3068 (2023)

مصطلحات موضوعية: thrombotic microangiopathy, thrombotic thrombocytopenic purpura, ADAMTS13 protein, diagnosis, prognosis, child, Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2077-0383/12/9/3068Test; https://doaj.org/toc/2077-0383Test

الوصول الحر: https://doaj.org/article/ed7a87cd2e8345b788d01ecd53780c34Test

المؤلفون: Agnès Veyradier, Sylvia Faict, Gaëlle Bécel, Adrien Picod, Paul Coppo, Raïda Bouzid

المساهمون: Hematology, Faculty of Medicine and Pharmacy

مصطلحات موضوعية: medicine.medical_specialty, Thrombotic microangiopathy, Purpura, Thrombotic Thrombocytopenic, business.industry, Translational medicine, Thrombotic thrombocytopenic purpura, ADAMTS13 Protein, Hematology, Disease, medicine.disease, Prognosis, ADAMTS13, Clinical research, hemic and lymphatic diseases, medicine, Humans, Rituximab, Caplacizumab, Intensive care medicine, business, Translational Science, Biomedical, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc8006f6f66b50fb5fa14cdabde0aedTest
https://doi.org/10.1055/a-1332-3066Test

المؤلفون: Paul Coppo, Adrien Picod, Agnès Veyradier

المصدر: Journal of thrombosis and haemostasis : JTHREFERENCES. 19(1)

مصطلحات موضوعية: medicine.medical_specialty, Thrombotic microangiopathy, medicine.medical_treatment, Thrombotic thrombocytopenic purpura, Salvage therapy, ADAMTS13 Protein, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Von Willebrand factor, law, Medicine, Humans, Intensive care medicine, biology, Plasma Exchange, Purpura, Thrombotic Thrombocytopenic, business.industry, Immunosuppression, Hematology, Single-Domain Antibodies, medicine.disease, ADAMTS13, biology.protein, Caplacizumab, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1860e65b679151ccd9bd1b3eca992016Test
https://pubmed.ncbi.nlm.nih.gov/33236389Test

المؤلفون: Paul Coppo, Adrien Picod, François Provôt

المساهمون: Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Séminaire d'Études Médiévales Hispaniques de Paris-Sorbonne (SEMH-SORBONNE), Civilisations et Littératures d'Espagne et d'Amérique du Moyen-Age aux Lumières (CLEA), Université Paris-Sorbonne (UP4)-Université Paris-Sorbonne (UP4)

المصدر: La Presse Médicale
La Presse Médicale, Elsevier Masson, 2019, 48, pp.319-327. ⟨10.1016/j.lpm.2019.08.024⟩

مصطلحات موضوعية: Anemia, Hemolytic, Anemia, [SDV]Life Sciences [q-bio], Thrombotic thrombocytopenic purpura, ADAMTS13 Protein, Disease, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, hemic and lymphatic diseases, medicine, Humans, Immunologic Factors, Molecular Targeted Therapy, Autoantibodies, Clinical Trials as Topic, Plasma Exchange, Purpura, Thrombotic Thrombocytopenic, business.industry, Autoantibody, General Medicine, Single-Domain Antibodies, medicine.disease, ADAMTS13, Pathophysiology, Acetylcysteine, 3. Good health, Purpura, Immunology, Therapeutic plasma exchange, medicine.symptom, Rituximab, business, Forecasting, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f490958e448f9b344b684d5a7f4b0d35Test
https://hal.archives-ouvertes.fr/hal-03488830Test

المؤلفون: Adrien Picod, Paul Coppo

المساهمون: Sorbonne Université (SU)

المصدر: Transfusion and Apheresis Science
Transfusion and Apheresis Science, Elsevier, 2019, 58, pp.273-277. ⟨10.1016/j.transci.2019.04.012⟩

مصطلحات موضوعية: Thrombotic microangiopathy, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Thrombotic thrombocytopenic purpura, ADAMTS13 Protein, Disease, 030204 cardiovascular system & hematology, Bioinformatics, 03 medical and health sciences, Drug Delivery Systems, 0302 clinical medicine, Von Willebrand factor, hemic and lymphatic diseases, von Willebrand Factor, medicine, Humans, Purpura, Thrombocytopenic, Idiopathic, Plasma Exchange, biology, business.industry, Hematology, Single-Domain Antibodies, medicine.disease, ADAMTS13, 3. Good health, biology.protein, Plasmapheresis, Rituximab, Caplacizumab, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f43a8c3277de26617aaa41c4b6a205Test
https://hal.archives-ouvertes.fr/hal-03484463/file/S1473050219300618.pdfTest

المؤلفون: Paul Coppo, Adrien Picod

المساهمون: Service d'hématologie clinique et de thérapie cellulaire [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Sorbonne Université (SU)

المصدر: Expert Review of Hematology
Expert Review of Hematology, Taylor & Francis, 2019, 12 (6), pp.461-471. ⟨10.1080/17474086.2019.1619170⟩

مصطلحات موضوعية: medicine.medical_specialty, Thrombotic microangiopathy, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Thrombotic thrombocytopenic purpura, von Willebrand factor, caplacizumab, 03 medical and health sciences, 0302 clinical medicine, rituximab, Von Willebrand factor, hemic and lymphatic diseases, medicine, Humans, thrombotic thrombocytopenic purpura, Intensive care medicine, biology, Plasma Exchange, Purpura, Thrombotic Thrombocytopenic, business.industry, Immunosuppression, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, medicine.disease, ADAMTS13, Combined Modality Therapy, 3. Good health, thrombotic microangiopathy, plasmapheresis, 030220 oncology & carcinogenesis, biology.protein, Rituximab, Plasmapheresis, Caplacizumab, business, Immunosuppressive Agents, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf729a7bd3ef86460cacc78f9c9941dTest
https://pubmed.ncbi.nlm.nih.gov/31092093Test